{
}
Amgen is set to launch its Eylea biosimilar, Pavblu, after a court ruling lifted a temporary injunction that had blocked its introduction. Despite Regeneron's claims of patent infringement and plans to continue legal battles, analysts suggest Amgen's move may be a tactic to prompt a settlement. The legal dispute intensified after a district court denied Regeneron's request for a preliminary injunction, allowing Amgen to proceed with its launch "at risk."
Biocon Biologics
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Amgen prepares to launch Eylea biosimilar amid ongoing legal battles
United States Dollar
Formycon AG
Biogen Inc.
Regeneron Pharmaceuticals, Inc.
Amgen Inc.
Sandoz Group AG
Biocon Biologics
USA
Brian Skorney
Christopher Raymond
Show more
16:20 23.10.2024
Trending
Subcategory
Corporate News
Stock Market Updates
Industry Trends
Finance Mergers & Acquisitions
Global Financial Events
Retail and Consumer Goods
Market Analysis and Predictions
CEO Changes
Banking Regulations
Industry Mergers & Acquisitions
Global Trade Developments
Energy Sector Developments
Startups & Entrepreneurship
Government Policies
Domestic Politics
Supply Chain Management
Financial Scams and Security
Central Bank Actions
Hedge Funds & Private Equity
Private Equity Deals
Countries:
Companies:
Tesla, Inc.
Barclays PLC
JPMorgan Chase & Co.
Apple Inc.
UBS Group AG
NVIDIA Corporation
Morgan Stanley
Capital One Financial Corporation
BNP Paribas SA
The Goldman Sachs Group, Inc.
Bank of America Corporation
Deutsche Bank RV Global PP
Commerzbank AG
Amazon.com, Inc.
SpaceXCoin USD
Credit Suisse Real Estate Fund Siat
Wells Fargo & Company
Citigroup Inc.
Microsoft Corporation
Raiffeisen Bank International AG
Currencies:
United States Dollar
Euro
Chinese Yuan
Indian Rupee
Swiss Franc
British Pound Sterling
Vietnamese Đồng
Hong Kong Dollar
Australian Dollar
United Arab Emirates Dirham
Singapore Dollar
South Korean Won
Thai Baht
Norwegian Krone
Danish Krone
Swedish Krona
Russian Ruble
Ghanaian Cedi
Canadian Dollar
Turkish Lira
People: